Clinical characterization of mpox including monitoring the use of therapeutic interventions: statistical analysis plan, 13 October 2023

Overview

The statistical analysis plan for mpox describes how data will be used to understand presenting conditions, morbidity and mortality, and subgroup analysis in key populations thought to be at risk of poor outcomes. The WHO will use these analyses to help clinicians, national programs, and member states to optimize patient management and public health response strategies.

An updated version of this document is available here